Next report date
Report period
H1 2024
EPS estimate
−1.13USD
Revenue estimate
5.03 MUSD
−2.63USD
−119.38 MUSD
18.89 MUSD
50.90 M
About INVENTIVA
Sector
Industry
CEO
Frédéric Cren
Website
Headquarters
Daix
Employees (FY)
123
Founded
2011
FIGI
BBG00VM4C335
Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
